MARY-ESTHER GURNEY: Open Payments
NPI 1487823043 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,607 in 97 payments from 18 companies in 2025. Trend: 2023 $463 · 2024 $1,018 · 2025 $1,607
Food & beverage: $1,462Education: $145
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 20 | $271 |
| Arcutis Biotherapeutics, Inc. | 24 | $255 |
| Incyte Corporation | 13 | $197 |
| Amgen Inc. | 8 | $139 |
| UCB, Inc. | 5 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Organon LLC | 3 | $93 |
| ABBVIE INC. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
Products named: Zoryve, NEMLUVIO, OPZELURA, DUPIXENT, OTEZLA, Bimzelx, RINVOQ, TREMFYA.
Industry payments across TX — which companies pay providers there.
